Target intelligence / Profile preview

Intimin (Eae)

Target
Eae
Molecular classification
Bacterial adhesin, Outer membrane protein, Inverse autotransporter, Other
01

Overview

Intimin is a 94 kDa outer membrane protein and a critical virulence factor found in Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic E. coli (EHEC) [2, 3]. It is encoded by the eae gene and functions as an adhesin that mediates the intimate attachment of bacteria to host intestinal epithelial cells [1, 5]. This attachment is achieved through a unique mechanism where the bacteria first inject their own receptor, the Translocated intimin receptor (Tir), into the host cell membrane via a Type III secretion system [2, 7]. Intimin then binds to the extracellular domain of Tir, triggering a signaling cascade that leads to actin polymerization and the formation of characteristic pedestal structures, known as attaching and effacing (A/E) lesions [5, 11]. Because intimin is essential for colonization and pathogenesis, it is a primary target for the development of anti-adhesion therapies and vaccines aimed at preventing EHEC and EPEC infections [4, 10]. Current therapeutic strategies focus on using recombinant intimin fragments or anti-intimin antibodies to block bacterial binding, thereby neutralizing the pathogen's ability to cause disease without exerting the selective pressure associated with traditional antibiotics [9, 16].

Other names
EaeAAttachment and effacing proteinIntimin-alphaIntimin-betaIntimin-gammaIntimin-deltaIntimin-epsilon
02

Mechanism of action

Inhibition of bacterial adhesion to host intestinal epithelial cells by blocking the Intimin-Tir interaction.

03

Biological functions

Bacterial adhesionAttaching and effacing (A/E) lesion formationActin pedestal formationPeptidoglycan bindingOther
04

Disease associations

InfectionOther
05

Safety considerations

Subtype-specific immunity (cross-protection challenges)Incomplete protection leading to asymptomatic bacterial sheddingChallenges in effective mucosal delivery
06

Interacting drugs

Recombinant Intimin-alpha (Int280α)

2 more in the full profile.

07

Biomarkers

eae gene presence (PCR)Intimin protein expressionAnti-intimin antibodies

Beyond the preview

Go deeper on Intimin (Eae).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intimin (Eae).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call